From sample to clinical recommendation: the Rx Report algorithm.
The 90+ medications analyzed in the Rx Report panel.
The 59-gene panel powering the Rx Report.
How your sample is processed, including the VNTR step that sets Rx Report apart.
Brain-receptor pharmacodynamic testing and pharmacist-guided recommendations.
See exactly what you receive: preview a real Rx Report.
How to collect your sample and use the kit.
Start your journey to better mental health with support and science on your side.
How genes can influence the way medications work for you.
The methodology that ties our four products together.
Our mechanism-based, multigene approach to pharmacodynamic assessment.
The neurochemistry behind NeuroMapp's clinical interpretations.
The free questionnaire that maps your current neurochemical state across key brain regions.
How clinical support tools guide treatment decisions.
How different medication classes affect neurotransmitter levels.
The peer-reviewed sources behind our methodology.
Support safer prescribing with pharmacogenomic insights you can apply at the point of care.
Make more confident medication decisions with clear reports tailored to each patient's profile.
Complement therapy plans with medication insights that help reduce trial-and-error setbacks.
Empower your patients with personalized medication insights and better outcomes.
Enable faster, better-tolerated treatment decisions that can improve outcomes and reduce downstream costs.
Support return-to-function plans with clearer medication fit insights for complex mental-health cases.
Strengthen mental-health benefits with evidence-informed tools that support employees and program value.
Learn who we are, what we do, and why we built PPI.
Real-world examples showing how reports can guide decisions.
Practical reads on genetics, mental health, and medication decisions.
Visit PGx Lab Solutions, our pharmacogenetic testing laboratory.
Quick answers to common questions about testing, results, and next steps.
Reach out to our team. We're here to help.
Educational glossary and useful links.
You are not eligible for reimbursement of a pharmacogenomic test by your Equitable benefits plan. However, you can still proceed with a test at the preferred price of $479 plus tax. Do you wish to proceed?
